Document:

[EXHIBIT 10.20]

                     SECRETARY'S CERTIFICATE

     The undersigned, [          ], Secretary of Med Gen, Inc., a
Nevada corporation (the "Company"), in connection with the
authorization and issuance of 8% Callable Secured Convertible
Notes in the aggregate principal amount of One Million Five
Hundred Forty Thousand Dollars ($1,540,000) and Warrants to
purchase an aggregate of 1,540,000 shares of the Company's Common
Stock, in accordance with the Securities Purchase Agreement dated
March 30, 2005, by and among the Company and each of the
purchasers set forth on the signature pages thereto (the "Private
Placement"), hereby certifies that:

     1.   He is the duly appointed Secretary of the Company.

     2.   Attached as Exhibit A hereto is a true and complete copy of
the Articles of Incorporation of the Company, as amended through
the date hereof; no action has been taken by the Company in
contemplation of any amendment of said Articles of Incorporation
or any liquidation, dissolution, merger or consolidation of the
Company.

     3.   Attached as Exhibit B hereto is a true and complete copy of
the Bylaws of the Company, as amended through the date hereof.

     4.   Attached as Exhibit C hereto is a true and complete copy of
the resolutions duly adopted by the Board of Directors of the
Company by unanimous written consent on March__, 2005; such
resolutions remain in full force and effect and have not been
rescinded, modified or supplemented and no other corporate
resolutions have been adopted by the Company in connection with
the Private Placement.

     IN WITNESS WHEREOF, the undersigned has executed this
Secretary's Certificate as of the _____ day of March, 2005.

                                   _______________________________
                                   [               ]
                                   Secretary

<PAGE>

                      OFFICER'S CERTIFICATE

     The undersigned, Paul B. Kravitz, Chief Executive Officer of
Med Gen, Inc., a Nevada corporation (the "Company"), in
connection with the authorization and issuance of 8% Callable
Secured Convertible Notes in the aggregate principal amount of
One Million Five Hundred Forty Thousand Dollars ($1,540,000) and
Warrants to purchase an aggregate of 1,540,000 shares of the
Company's Common Stock, in accordance with the Securities
Purchase Agreement dated March 30, 2005 by and among the Company
and each of the purchasers set forth on the signature pages
thereto (the "Purchase Agreement"), hereby certifies that:

     1.   He is the duly appointed President and Chief Executive
Officer of the Company.

     2.   The representations and warranties made by the Company in
Section 3 of the Purchase Agreement are true and correct in all
material respects as of the date of this Officer's Certificate.
The capitalization of the Company described in Section 3(c) of
the Purchase Agreement has not changed as of the date hereof.

     3.   As of the date hereof, the Company has satisfied and duly
performed all of the conditions and obligations specified in
Section 7 of the Purchase Agreement to be satisfied on or prior
to the Closing Date (as defined in the Purchase Agreement) or
such conditions and obligations have been waived.

     4.   The Company has complied with or, if compliance prior to
Closing (as defined in the Purchase Agreement) is not required,
promptly following the Closing the Company will comply with, the
filing requirements in respect of this transaction under (a)
Regulation D under the Securities Act of 1933, as amended (the
"1933 Act") (and applicable Blue Sky regulations) and (b) the
Securities Exchange Act of 1934, as amended.

     5.   There has been no adverse change in the business, affairs,
prospects, operations, properties, assets or condition of the
Company since December 30, 2004, the date of the Company's most
recent audited financial statements delivered to the Buyers (as
defined in the Purchase Agreement), other than matters which
would not, individually or in the aggregate, have a Material
Adverse Effect (as defined in the Purchase Agreement).

     6.   The Company is qualified as a foreign corporation in all
jurisdictions in which the Company owns or leases properties, or
conducts any business except where failure of the Company to be
so qualified would not have a Material Adverse Effect (as defined
in the Purchase Agreement).

     IN WITNESS WHEREOF, the undersigned has executed this
Officer's Certificate as of the ____ day of March, 2005.

                                   _________________________________
                                   Paul B. Kravitz
                                   Chief Executive Officer

<PAGE>[EXHIBIT 10.21]

             [To be reprinted on Company letterhead]

                         March __, 2005

____________________
____________________
____________________
____________________

Ladies and Gentlemen:

          Med Gen, Inc., a Nevada corporation (the "Company"),
and certain investors (the "Investors") have entered into a
Securities Purchase Agreement dated as of March 30, 2005 (the
"Agreement") providing for the issuance of 8% Callable Secured
Convertible Notes in the aggregate principal amount of $1,540,000
(the "Notes") and warrants to purchase an aggregate of 1,540,000
shares of the Company's Common Stock (the "Warrants"), for the
aggregate consideration of $1,540,000.

          You are hereby irrevocably authorized and instructed to
reserve a sufficient number of shares of Common Stock (initially,
93,500,000 shares) of the Company for issuance upon full
conversion of the Notes and exercise of the Warrants in
accordance with the respective terms thereof.  You are hereby
further irrevocably authorized and directed to issue the shares
of Common Stock so reserved upon your receipt from the Company of
a notice of conversion ("Notice of Conversion") or exercise
agreement ("Exercise Agreement") duly executed by an Investor in
accordance with the terms of such notices and agreements and the
Notes and Warrants, as applicable.

          A copy of a Form of Note and Form of Warrant is
attached hereto.  You should familiarize yourself with your
issuance and delivery obligations, as Transfer Agent, contained
therein.  The shares to be issued are to be registered in the
names of the registered holder of the securities submitted for
conversion or exercise.

          So long as you have previously received confirmation
from the Company that the shares have been registered under the
1933 Act or otherwise may be sold pursuant to Rule 144 without
any restriction as to the number of securities as of a particular
date that can then be immediately sold, such shares should be
transferred, at the option of the holder of the Notes or Warrants
as specified in the Notice of Conversion or Exercise Agreement,
as applicable, either (i) electronically by crediting the account
of a Prime Broker with the Depository Trust Company through its
Deposit Withdrawal Agent Commission system or (ii) in
certificated form without any legend which would restrict the
transfer of the shares, and you should remove all stop-transfer
instructions relating to such shares.  Until such time as you are
advised by Company counsel that the shares have been registered
under the 1933 Act or otherwise may be sold pursuant to Rule 144
without any restriction as to the number of securities as of a
particular date that can then be immediately sold, you are hereby
instructed to place the following legends on the certificates:

<PAGE>

     THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
     BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
     AMENDED.  THE SECURITIES MAY NOT BE SOLD, TRANSFERRED
     OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
     STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN
     OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE
     CUSTOMARY FOR OPINIONS OF COUNSEL IN COMPARABLE
     TRANSACTIONS, THAT REGISTRATION IS NOT REQUIRED OR
     UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

          The legend set forth above shall be removed and you are
instructed to issue a certificate without such legend to the
holder of any shares upon which it is stamped, if, unless
otherwise required by applicable state securities laws, (a) such
shares are registered for sale under an effective registration
statement filed under the 1933 Act or otherwise may be sold
pursuant to Rule 144 without any restriction as to the number of
securities as of a particular date that can then be immediately
sold, (b) such holder provides the Company with an opinion of
counsel, in form, substance and scope customary for opinions of
counsel in comparable transactions, to the effect that a public
sale or transfer of such security may be made without
registration under the 1933 Act and such sale or transfer is
effected or (c) such holder provides the Company with reasonable
assurances that such shares can be sold pursuant to Rule 144.

          The Investors are intended to be and are third party
beneficiaries hereof, and no amendment or modification to the
instructions set forth herein may be made without the consent of
such Investors.

                                   Very truly yours,

                                   MED GEN, INC.

                                   Paul B. Kravitz
                                   Chairman and Chief Executive
                                   Officer

Acknowledged:

______________________________
Transfer Agent

                              2
<PAGE>EXHIBIT 4.7

                                                                  [  ] May 2005

Dear

Proposed enhancement to annual bonus to be delivered in shares

As mentioned in Ian Russell's letter of 14th May 2005, your maximum bonus under
the Annual Incentive Plan ("AIP") will (subject to your agreement to the terms
set out below) now be one third above your previous maximum level. This
additional uplift will, however, only be delivered in the form of American
Depositary Shares in the capital of Scottish Power PLC (Shares) which will be
known as "Deferred Incentive Shares".

Terms of Deferred Incentive Shares

The Company will arrange for a gross amount equal to $[ ] to be used to acquire
Shares through the Company's broker Smith Barney, after the applicable tax
withholding has been deducted, at the market price obtainable on [      ]. (The
actual market price may be an average share price of purchases made across a
number of days).

The Shares so acquired will be registered in your name in an arrangement
administered by Smith Barney and will be awarded to you on the following terms:

1. The Company requests that you refrain from selling your Deferred Incentive
Shares for three years from [        ], to [       ].

2. If you choose to sell your Deferred Incentive Shares (or if your total
shareholdings fall below any number of Shares required to be held pursuant to
the Scottish Power Shareholding Policy, if applicable to you) the Remuneration
Committee (or the Group Human Resources Director as appropriate) are unlikely to
award you any similar Share-based bonus enhancements in future years.

<PAGE>

3. The Remuneration Committee (or the Group Human Resources Director, as
appropriate) will consider requests to sell your Deferred Incentive Shares in
the event of financial hardship or special circumstances.

If you DO NOT wish to receive Deferred Incentive Shares, please contact
[       ] as soon as possible on [        ]. If we do not hear from you by the
end of business on [         ], Deferred Incentive Shares will be acquired for
you and we will assume you have accepted the terms of the Deferred Incentive
Shares as detailed above.

Yours sincerely

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]